If we get FDA approval a range of potential positive benefits flow.
Imminent significant cashflow
Increased potential to close ROW
Increased potential value for ROW
Potential ability to fast track 2591 in the 4 current indications
Increased potential for 2591 licensing deal
Potential to implement additional clinical trials for alternative indications in 2591
Imminent inclusion in asx200
Potential inclusion in asx100 (additional significant investors)
That’s a lot of potential value and increased buying pressure to overcome should anyone be trying to keep the shareprice below $20 a few months after approval.
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-3586
-
- There are more pages in this discussion • 9,020 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B |
Open | High | Low | Value | Volume |
$13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 11501 | $13.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.18 | 1539 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 464 | 13.100 |
2 | 264 | 13.070 |
1 | 300 | 13.020 |
2 | 300 | 13.010 |
9 | 17634 | 13.000 |
Price($) | Vol. | No. |
---|---|---|
13.210 | 1700 | 1 |
13.430 | 2400 | 1 |
13.450 | 150 | 1 |
13.480 | 2000 | 1 |
13.490 | 1700 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |